Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- BOUL.ST
- Price
- 7.72
- Stock movement up
- +0.13 (1.71%)
- Company name
- Boule Diagnostics AB
- Exchange
- (ST ,
- Currency
- SEK )
- Sector
- Healthcare >Medical Devices
- Market cap
- 299.91M
- Ent value
- 566.31M
- Price/Sales
- 0.53
- Price/Book
- 1.18
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- 6.84
- PEG
- -
- EPS growth
- -15.54%
- 1 year return
- -19.22%
- 3 year return
- -37.88%
- 5 year return
- -29.27%
- 10 year return
- 6.73%
Last updated: 2025-04-15
DIVIDENDS
BOUL.ST does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | 4.95 |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.53 |
| Price to Book | 1.18 |
| EV to Sales | 1.01 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 38.83M |
| EPS (TTM) | -5.47 |
| FCF per share (TTM) | -0.62 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 563.40M |
| Gross profit (TTM) | 254.40M |
| Operating income (TTM) | -247.20M |
| Net income (TTM) | -212.52M |
| EPS (TTM) | -5.47 |
| EPS (1y forward) | 1.13 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 45.15% |
| Operating margin (TTM) | -43.88% |
| Profit margin (TTM) | -37.72% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 17.20M |
| Net receivables | 153.20M |
| Total current assets | 229.90M |
| Goodwill | 85.80M |
| Intangible assets | 80.40M |
| Property, plant and equipment | 35.70M |
| Total assets | 538.50M |
| Accounts payable | 29.00M |
| Short/Current long term debt | 178.30M |
| Total current liabilities | 221.70M |
| Total liabilities | 283.60M |
| Shareholder's equity | 254.90M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 60.60M |
| Capital expenditures (TTM) | 84.50M |
| Free cash flow (TTM) | -23.90M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -83.38% |
| Return on Assets | -39.47% |
| Return on Invested Capital | -49.41% |
| Cash Return on Invested Capital | -5.56% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 7.49 |
| Daily high | 7.72 |
| Daily low | 7.49 |
| Daily Volume | 18K |
| All-time high | 76.48 |
| 1y analyst estimate | 9.50 |
| Beta | 0.48 |
| EPS (TTM) | -5.47 |
| Dividend per share | - |
| Ex-div date | 6 May 2022 |
| Next earnings date | 5 May 2025 |
Downside potential
Loading...
Downside potential data
| BOUL.ST | S&P500 | |
| Current price drop from All-time high | -89.90% | -12.04% |
| Highest price drop | -91.24% | -56.47% |
| Date of highest drop | 13 Nov 2024 | 9 Mar 2009 |
| Avg drop from high | -49.11% | -11.07% |
| Avg time to new high | 94 days | 12 days |
| Max time to new high | 1670 days | 1805 days |
COMPANY DETAILS
Marketcap
299.91M
Marketcap category
Small-cap
Description
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, Medonic, and Quintus brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics companies. Boule Diagnostics AB (publ) was founded in 1956 and is headquartered in Spånga, Sweden.
Employees
200
Website
Investor relations
-
SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Despite a decline in sales, Boule Diagnostics AB (STU:8BD) reports significant gains in operating profit and margin, driven by strategic restructuring and OEM sales growth.
October 28, 2024
Despite a dip in net sales, Boule Diagnostics AB (STU:8BD) shows resilience with improved cash flow and strategic cost efficiencies.
October 9, 2024